Immunotherapy Skin Patch Tames Peanut Allergy Reactions in Kids

By News Health
33 minutes Ago

(MedPage Today) — PHILADELPHIA — Peanut allergy immunotherapy delivered by an investigational skin patch increased the proportion of children ages 4 to 7 years who could tolerate a dose of peanut protein in the phase III VITESSE trial.
After…

Source link : https://www.medpagetoday.com/meetingcoverage/aaaai/120108

Author :

Publish date : 2026-03-02 15:51:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Third of Exhausted Doctors Have Cried at Work, Survey Finds

The Doctors Paid to Treat Epstein's 'Girls'; Swine Flu Concern; $1.5B for Measles?

Widely Used Procedure Questionable for Pancreatitis Patients

MRI-Guided Chemotherapy Improves Survival in Breast Cancer

Ants capture carbon dioxide from the air and turn it into armour

FDA Okays New Indications for Once-Weekly Growth Hormone